Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: trans-activation and repression by CCAAT/enhancer binding protein.
about
Cloning and characterization of a novel human hepatocyte transcription factor, hB1F, which binds and activates enhancer II of hepatitis B virusX region mutations of hepatitis B virus related to clinical severityGenetic variation of occult hepatitis B virus infectionRoles of hepatocyte nuclear factors in hepatitis B virus infectionSuppression of hepatitis B virus core promoter by the nuclear orphan receptor TR4Transcription repression of human hepatitis B virus genes by negative regulatory element-binding protein/SONThe alpha1-fetoprotein locus is activated by a nuclear receptor of the Drosophila FTZ-F1 familyIdentification of multiple transcription factors, HLF, FTF, and E4BP4, controlling hepatitis B virus enhancer II.The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replicationIn vivo effects of mutations in woodchuck hepatitis virus enhancer II.The core promoter of hepatitis B virus.In vivo regulation of hepatitis B virus replication by peroxisome proliferators.Replication of the wild type and a natural hepatitis B virus nucleocapsid promoter variant is differentially regulated by nuclear hormone receptors in cell culture.MicroRNAs associated with HBV infection and HBV-related HCC.LRH-1/hB1F and HNF1 synergistically up-regulate hepatitis B virus gene transcription and DNA replication.Transcriptional and posttranscriptional control of hepatitis B virus gene expressionMechanisms of inhibition of nuclear hormone receptor-dependent hepatitis B virus replication by hepatocyte nuclear factor 3beta.Doxorubicin Activates Hepatitis B Virus Replication by Elevation of p21 (Waf1/Cip1) and C/EBPα Expression.Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication.Members of the nuclear receptor superfamily regulate transcription from the hepatitis B virus nucleocapsid promoter.Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2.Quantitative evaluation of hepatitis B virus mutations and hepatocellular carcinoma risk: a meta-analysis of prospective studies.Evidence for posttranscriptional regulation of C/EBPalpha and C/EBPbeta isoform expression during the lipopolysaccharide-mediated acute-phase response.Repression of enhancer II activity by a negative regulatory element in the hepatitis B virus genome.Differentiated liver cell specificity of the second enhancer of hepatitis B virusCharacterization of functional Sp1 transcription factor binding sites in the hepatitis B virus nucleocapsid promoter.Multiple forms of C/EBP beta bind the EFII enhancer sequence in the Rous sarcoma virus long terminal repeat.Regulation of transcription from the hepatitis B virus major surface antigen promoter by the Sp1 transcription factor.Repression of liver-specific hepatitis B virus enhancer 2 activity by adenovirus E1A proteins.Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus.C/EBP-like proteins binding to the functional box-alpha and box-beta of the second enhancer of hepatitis B virusMicroRNAs in Liver Health and DiseaseA novel hepatitis B virus (HBV) genetic element with Rev response element-like properties that is essential for expression of HBV gene products.Effects of age on the posttranscriptional regulation of CCAAT/enhancer binding protein alpha and CCAAT/enhancer binding protein beta isoform synthesis in control and LPS-treated liversRegulation of hepatitis B virus gene expression by its two enhancers.An "attenuator domain" is sandwiched by two distinct transactivation domains in the transcription factor C/EBP.Functional analysis of a liver-specific enhancer of the hepatitis B virusInteractions of Hepatitis B Virus Infection with Nonalcoholic Fatty Liver Disease: Possible Mechanisms and Clinical Impact.The SIRT1 inhibitor, nicotinamide, inhibits hepatitis B virus replication in vitro and in vivo.Expression of microRNA-155 correlates positively with the expression of Toll-like receptor 7 and modulates hepatitis B virus via C/EBP-β in hepatocytes.
P2860
Q22004000-C2B7E597-700B-45B6-A9E1-06CDE8C56C4BQ26746928-AF6EFFEB-8EE6-4791-96E6-7B54D37BD8A2Q26751031-E44487B8-3507-4E95-A757-53D3C2B402A0Q28069574-9746D633-12F7-4889-8539-CBF137641F2EQ28202578-EBAF6C8A-3534-4A63-83C0-EA7D62B05D8CQ28212953-5F2DB287-3891-4534-9D3D-B326ED040ABFQ28571516-F7E77924-BCBD-4627-9B33-6188C275B7CEQ30831777-88C80720-EEDB-49F8-9652-63C458043E65Q33754980-376D94A6-0BD2-43C2-90FB-AF52C917F5C0Q33783526-9DC5D615-EE6F-488F-AD2F-CB038413AED7Q33801359-06588B93-A929-49D5-AD82-CFB1F6BAB595Q33825523-DE871885-B827-4EE2-A722-9C77458D0D5CQ33845008-9BFA99F2-42BF-423D-A361-2E4E992C538FQ34284404-B4196578-1D48-4856-8753-45EE81BFA532Q34290447-8A55A810-860A-49A6-ACCA-03949D7BBC4BQ34330559-B128855B-6176-4DDD-9BF5-E7292C0624B4Q34344259-ECC63005-42B5-4C52-AD38-298053ABAB26Q35801644-FB51432E-5F21-480A-8D3F-63B431542291Q35867756-C1559C57-1074-4120-912C-84DEBEB69080Q35876404-CFABCD93-9AFF-40C2-9A79-53032AC27015Q36098721-127F5F70-D211-4217-8963-01DE2FE9A0A5Q36227142-8405EAC7-9622-470C-84BE-F15A40BF48CAQ36559345-EA723745-4251-4159-B4C5-05BFF9F0529DQ36629822-BF6101F4-8999-4210-B47F-FF8B13A71278Q36639046-B15D8459-76D1-4D4D-A391-D3E844909A4BQ36643638-36696CD6-70CD-42A2-B6F3-3392AACA57ACQ36657531-B1403B5F-30FC-489C-A009-8C5669353BFCQ36686383-DF8DAAD6-5C32-4A53-A5F1-1FB550EC91CBQ36687445-1E3525AD-08B7-4EA4-8D28-60506AAA9CDFQ36698734-67F2D576-861B-4EE9-9394-016A5D0BD685Q36735975-8A1D7280-A593-48D6-B597-9B7381F8A0E9Q36739805-C3C4893A-8078-4193-9835-AF2E1FBE4768Q36827420-60FD822F-952E-47F2-8F34-C02AC64E4203Q36878810-B955091C-8F42-4328-9880-F9172147D765Q36917295-32D0FC47-B2F8-4DBD-A68B-D4FF5CC6684DQ36959311-2E6BCC44-62FC-45EC-B4E4-858871C9EDB2Q37498262-FAEA2AFD-6D2F-4438-A955-277B1259A0CFQ38538187-F88C3516-305B-4FED-A0DB-413FF31E32E4Q38812202-4DEB0824-349C-42F6-A331-3E8B6A5BE593Q38905804-73159321-E6C5-433C-90E2-C949CA20C6B8
P2860
Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: trans-activation and repression by CCAAT/enhancer binding protein.
description
1990 nî lūn-bûn
@nan
1990 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Multiple liver-specific factor ...... CAAT/enhancer binding protein.
@ast
Multiple liver-specific factor ...... CAAT/enhancer binding protein.
@en
type
label
Multiple liver-specific factor ...... CAAT/enhancer binding protein.
@ast
Multiple liver-specific factor ...... CAAT/enhancer binding protein.
@en
prefLabel
Multiple liver-specific factor ...... CAAT/enhancer binding protein.
@ast
Multiple liver-specific factor ...... CAAT/enhancer binding protein.
@en
P2093
P2860
P356
P1476
Multiple liver-specific factor ...... CAAT/enhancer binding protein.
@en
P2093
A Siddiqui
J Letovsky
M López-Cabrera
P2860
P304
P356
10.1073/PNAS.87.13.5069
P407
P577
1990-07-01T00:00:00Z